Cite
Mateos MV, Bladé J, Bringhen S, et al. Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma. J Clin Med. 2020;9(10)doi: 10.3390/jcm9103120.
Mateos, M. V., Bladé, J., Bringhen, S., Ocio, E. M., Efebera, Y., Pour, L., Gay, F., Sonneveld, P., Gullbo, J., & Richardson, P. G. (2020). Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma. Journal of clinical medicine, 9(10), . https://doi.org/10.3390/jcm9103120
Mateos, María-Victoria, et al. "Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma." Journal of clinical medicine vol. 9,10 (2020). doi: https://doi.org/10.3390/jcm9103120
Mateos MV, Bladé J, Bringhen S, Ocio EM, Efebera Y, Pour L, Gay F, Sonneveld P, Gullbo J, Richardson PG. Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma. J Clin Med. 2020 Sep 27;9(10). doi: 10.3390/jcm9103120. PMID: 32992506; PMCID: PMC7601491.
Copy
Download .nbib